摘要 |
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes. |
申请人 |
Boehringer Ingelheim International GmbH |
发明人 |
BROEDL, Uli Christian;CHERNEY, David;DAIBER, Andreas;VON EYNATTEN, Maximilian;JOHANSEN, Odd-Erik;KIM, Gabriel Woojai;MAYOUX, Eric Williams;MUENZEL, Thomas;PERKINS, Bruce A.;SALSALI, Afshin;SOLEYMANLOU, Nima;WOERLE, Hans-Juergen |